Print Page

Letters to Trade
 
Mycophenolate: EMA recommends additional measures to prevent use in pregnancy (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. Mycophenolate: EMA recommends additional measures to prevent use in pregnancy WCAG  
Related Information:
The United Kingdom: Mycophenolate mofetil, mycophenolic acid: updated contracept... Posted 2018-02-07
European Union: Updated recommendations for contraception in men and women takin... Posted 2017-12-16
China: CFDA announcement on revision of package insert of mycophenolic acid rela... Posted 2017-03-29
Singapore: CellCept® (mycophenolate mofetil): teratogenic risk – important new p... Posted 2016-03-16
Canada: CellCept (mycophenolate mofetil) and MYFORTIC (mycophenolate sodium) - S... Posted 2016-01-19
Australia: Safety advisory: Mycophenolate mofetil - new contraindications relati... Posted 2015-12-22
The United Kingdom: Mycophenolate mofetil, mycophenolic acid: new pregnancy-prev... Posted 2015-12-15
European Union: EMA recommends additional measures to prevent use of mycophenola... Posted 2015-10-24
 
back